Arogo Capital Acquisition CORP Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

OTC.Pink
Arogo Capital Acquisition Corp. has amended its charter to extend the deadline for its initial business combination from June 29, 2026, to June 29, 2028, and to allow for stockholder actions via written consent.
OTC.Pink
Arogo Capital Acquisition Corp. and Bangkok Tellink Co., Ltd. have executed a definitive business combination agreement, valuing the transaction at $350 million, with plans to list the combined entity on The Nasdaq Global Market.
OTC.Pink
Mangrove Partners IM, LLC files Form 4 to report it is no longer subject to Section 16 of the Exchange Act after its ownership stake in Arogo Capital Acquisition Corp. fell below 10%.
OTC.Pink
Arogo Capital Acquisition Corp. successfully extended its business combination deadline to June 29, 2026, and removed limitations on share redemptions following a special stockholder meeting.
OTC.Pink
Arogo Capital Acquisition Corp. has signed a binding letter of intent with Bangkok Tellink Co., Ltd, signaling a potential merger that could take the telecommunications company public in the U.S.
OTC.Pink
Arogo Capital Acquisition Corp. has terminated its business combination agreement with Ayurcann Holdings Corp. due to Ayurcann's failure to deliver required financial statements and the transaction not being completed by the termination date.
OTC.Pink
Arogo Capital Acquisition Corp. deposited $40,000 to extend the deadline for its initial business combination by one month to October 29, 2024.
OTC.Pink
Arogo Capital Acquisition Corp. received notification of delisting from Nasdaq due to non-compliance with listing requirements and intends to transition to the OTCQB Market.
OTC.Pink
Arogo Capital Acquisition Corp. reports the conversion of all outstanding Class B common stock into Class A common stock on August 21, 2024, impacting voting power and economic interests of stockholders.
OTC.Pink
Arogo Capital Acquisition Corp. is facing potential delisting from the Nasdaq due to non-compliance with several listing rules, including minimum market value, number of total holders, and publicly held shares.
OTC.Pink
Arogo Capital Acquisition Corp. received a delisting notice from Nasdaq for failing to meet minimum market value and total holder requirements and has requested a hearing to appeal the decision.
OTC.Pink
Arogo Capital Acquisition Corp. stockholders approve an amendment allowing Class B common stock to be converted into Class A common stock on a one-for-one basis at any time before an initial business combination.
OTC.Pink
Ayurcann Holdings Corp. and Arogo Capital Acquisition Corp. have entered into a definitive business combination agreement, with a combined enterprise value estimated at U.S. $210 million.
OTC.Pink
Arogo Capital Acquisition Corp. received a Nasdaq notification regarding a deficiency in the minimum market value of listed securities, giving them until July 8, 2024, to regain compliance.